Barclays Maintains an 'Overweight' on PVH Corp (PVH); Raising Estimates on Good Qtr
Tweet Send to a FriendGet Alerts PVH Hot Sheet
Price: $120.28 +1.90%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade PVH Now!
Barclays maintains an 'Overweight' on PVH Corp (NYSE: PVH) price target of $100.00.
Analyst, Robert S. Drbul, said, "Given consistent top line momentum, particularly at Tommy Hilfiger, which has remained solid in Europe despite macroeconomic challenges, we are raising our 2012 and 2013 EPS estimates to $6.25 and $7.10 from $6.20 and $7.00, respectively. We continue to expect a $(0.20)-$(0.25) impact from FX in 2012."
For an analyst ratings summary and ratings history on PVH Corp click here. For more ratings news on PVH Corp click here.
Shares of PVH Corp closed at $77.37 yesterday, with a 52 week range of $51.15-$93.06.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Robert S. Drbul, said, "Given consistent top line momentum, particularly at Tommy Hilfiger, which has remained solid in Europe despite macroeconomic challenges, we are raising our 2012 and 2013 EPS estimates to $6.25 and $7.10 from $6.20 and $7.00, respectively. We continue to expect a $(0.20)-$(0.25) impact from FX in 2012."
For an analyst ratings summary and ratings history on PVH Corp click here. For more ratings news on PVH Corp click here.
Shares of PVH Corp closed at $77.37 yesterday, with a 52 week range of $51.15-$93.06.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
- Supernus (SUPN) PT Trimmed at Jefferies, But Survey Shows Significant Market Opportunity
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
